Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Bayer Healthcare presents new oral selective PI3K inhibitor

April 11, 2012

Preclinical and first clinical data disclosed on MLN-2480

April 11, 2012

Novel anticancer nanomedicine shows promise in clinical trial

April 10, 2012

Amgen presents first preclinical data on novel anticancer drug

April 10, 2012

ARMOR1 trial assesses safety of galeterone in prostate cancer

April 10, 2012

CSA-131 active against Gram-negative bacteria

April 10, 2012

Cell-based gene therapy is well tolerated in phase I study

April 10, 2012

First-in-class cancer immunotherapy well tolerated in phase I trial

April 10, 2012

Novel microRNA-based tests classify tumor types with high accuracy

April 5, 2012

Discovery and entry of ABT-199 into clinic reported at AACR meeting

April 5, 2012

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...